ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - valganciclovir 450 mg - film coated tablets - valganciclovir - valcyte is indicated for the induction and maintenance treatment of cytomegalovirus (cmv) retinitis in patients with acquired immunodeficiency syndrome (aids). valcyte is indicated for the prevention of cmv diseasein cmv-negative patients who have received a solid organ transplant from a cmv-positive donor.

ישראל - עברית - Ministry of Health

novartis pharma services ag - zoledronic acid 4 mg/vial - powder for solution for infusion - zoledronic acid - treatment of hypercalcaemia of malignancy. treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. prostate cancer should have progressed after treatment with at least one hormonal therapy.

ישראל - עברית - Ministry of Health

novartis pharma services ag - zoledronic acid 4 mg/vial - concentrate for solution for infusion - zoledronic acid - treatment of hypercalcaemia of malignancy. treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors , in conjunction with standard antineoplastic therapy. prostate cancer should have progressed after treatment with at least one hormonal therapy.

ישראל - עברית - Ministry of Health

abic marketing ltd - zoledronic acid as monohydrate 4 mg/vial - concentrate for solution for infusion - zoledronic acid - treatment of hypercalcaemia of malignancy. treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors , in conjunction with standard antineoplastic therapy. prostate cancer should have progressed after treatment with at least one hormonal therapy.

ישראל - עברית - Ministry of Health

abic marketing ltd - zoledronic acid as monohydrate 4 mg/vial - concentrate for solution for infusion - zoledronic acid - treatment of hypercalcaemia of malignancy. treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors , in conjunction with standard antineoplastic therapy. prostate cancer should have progressed after treatment with at least one hormonal therapy.

ישראל - עברית - Ministry of Health

amgen europe b.v. - denosumab - תמיסה להזרקה - denosumab 120 mg / 1.7 ml - denosumab - denosumab - prevention of skeletal related events (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with bone metastases from solid tumours.

ישראל - עברית - Ministry of Health

שמעון שסטוביץ בעמ - בישום הגוף

ישראל - עברית - Ministry of Health

שמעון שסטוביץ בעמ - בישום הגוף

ישראל - עברית - Ministry of Health

שמעון שסטוביץ בעמ - בישום העור

ישראל - עברית - Ministry of Health

שמעון שסטוביץ בעמ - בישום הגוף